We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-18.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$7.34B
AUM Growth
-$2.26B
Cap. Flow
-$62.6M
Cap. Flow %
-0.85%
Top 10 Hldgs %
20.25%
Holding
2,373
New
73
Increased
127
Reduced
630
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Healthcare 14.47%
3 Financials 13.19%
4 Industrials 9.16%
5 Consumer Discretionary 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AROW icon
1751
Arrow Financial
AROW
$723M
$182K ﹤0.01%
7,370
NPK icon
1752
National Presto Industries
NPK
$987M
$182K ﹤0.01%
2,572
TGH
1753
DELISTED
Textainer Group Holdings limited
TGH
$181K ﹤0.01%
22,079
LGTY
1754
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$181K ﹤0.01%
12,761
NWLI
1755
DELISTED
National Western Life Group, Inc. Class A
NWLI
$181K ﹤0.01%
1,054
HSKA
1756
DELISTED
Heska Corp
HSKA
$181K ﹤0.01%
3,277
FFWM
1757
DELISTED
First Foundation Inc
FFWM
$181K ﹤0.01%
17,720
CFB
1758
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$181K ﹤0.01%
+21,534
New +$260K
EBF icon
1759
Ennis
EBF
$559M
$181K ﹤0.01%
9,631
SRCE icon
1760
1st Source
SRCE
$2.13B
$181K ﹤0.01%
5,572
AER icon
1761
AerCap
AER
$23.5B
$180K ﹤0.01%
7,900
MYRG icon
1762
MYR Group
MYRG
$5.1B
$180K ﹤0.01%
6,874
FFIC
1763
DELISTED
Flushing Financial
FFIC
$179K ﹤0.01%
13,422
SRI icon
1764
Stoneridge
SRI
$201M
$179K ﹤0.01%
10,698
STOK icon
1765
Stoke Therapeutics
STOK
$2.02B
$179K ﹤0.01%
7,812
+3,050
+64% +$75.4K
CMO
1766
DELISTED
Capstead Mortgage Corp.
CMO
$179K ﹤0.01%
42,582
SKT icon
1767
Tanger
SKT
$4.42B
$178K ﹤0.01%
35,698
-53,321
-60% -$652K
URGN icon
1768
UroGen Pharma
URGN
$2.34B
$178K ﹤0.01%
9,990
MEET
1769
DELISTED
The Meet Group, Inc. Common Stock
MEET
$177K ﹤0.01%
30,234
+14,702
+95% +$83.8K
BFS
1770
Saul Centers
BFS
$865M
$177K ﹤0.01%
5,405
PLAY icon
1771
Dave & Buster's
PLAY
$370M
$176K ﹤0.01%
13,484
CPRX
1772
DELISTED
Catalyst Pharmaceutical
CPRX
$176K ﹤0.01%
45,807
+20,495
+81% +$84.1K
FLWS icon
1773
1-800-Flowers.com
FLWS
$261M
$176K ﹤0.01%
13,330
CCS icon
1774
Century Communities
CCS
$2.04B
$176K ﹤0.01%
12,109
MSBI icon
1775
Midland States Bancorp
MSBI
$698M
$175K ﹤0.01%
10,034

Similar funds

MetLife Investment Management's Q1 2020 Portfolio in Review

As of Q1 2020, MetLife Investment Management held 2,373 positions worth $7.34B, down 24% from $9.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q1 2020 filing shows 73 new, 127 increased, 630 reduced and 133 closed positions. Its largest new stake was iShares Broad USD Investment Grade Corporate Bond ETF: 719,093 shares worth $40.3M. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $52.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q1 2020 buy was iShares Broad USD Investment Grade Corporate Bond ETF: 719,093 shares worth $40.3M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $104M increase.
  • MetLife Investment Management's biggest Q1 2020 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $52.3M.
  • MetLife Investment Management fully exited Tallgrass Energy, LP Class A Shares in Q1 2020, selling an estimated $8.66M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $7.34B portfolio in Q1 2020.
  • MetLife Investment Management opened 73 new positions and closed 133 in Q1 2020.
  • MetLife Investment Management's portfolio value fell 24% quarter-over-quarter to $7.34B.

Based on MetLife Investment Management's 13F filing for Q1 2020, filed 15 May 2020.